Newer Volatile Anesthetic Agents in Cardiac Anesthesia: Review of Literature

Abstract Myocardial protection with volatile anesthetic agents have been suggested by multiple studies. These studies, however, are scattered and often limited to a particular aspect of cardiac anesthesia. Older inhalational like halothane is known cause significant hepatic damage in patients undergoing long duration surgeries while isoflurane marked vasodilating properties that also affects the coronary arteries leading “steal” phenomenon. Additionally, newer agents, sevoflurane desflurane, shown more prominent cardioprotective effects than older agents. We searched ScholarOne, Medline, Embase, Cochrane Central Register Controlled Trials (CENTRAL) Library. The medical subject headings (MeSH) terms “anaesthesia, inhalational,” intravenous, or TIVA,” “Cardiac anaesthesia Cardiac Surgery” were used. Additional studies identified review reference sections all eligible aim this article bring together evidences provide holistic view their benefits shortcomings